Skip to main content Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

43rd Parliament, 2nd Session
Meeting 9
Friday, November 27, 2020, 1:02 p.m. to 3:07 p.m.
Webcast
Presiding
Ron McKinnon, Chair (Liberal)

• Tom Kmiec for Chris d'Entremont (Conservative)
• Tom Kmiec for Larry Maguire (Conservative)
• Sameer Zuberi for Sonia Sidhu (Liberal)
Library of Parliament
• Dominique Montpetit, Analyst
• Karin Phillips, Analyst
House of Commons
• Michel Bédard, Deputy Law Clerk and Parliamentary Counsel
• Philippe Dufresne, Law Clerk and Parliamentary Counsel
Pursuant to the order of reference of Monday,October 26, 2020, the committee resumed its study of the emergency situation facing Canadians in light of the second wave of the COVID-19 Pandemic.

Philippe Dufresne made a statement and answered questions.

At 2:03 p.m., the sitting was suspended.

At 2:05 p.m., the sitting resumed.

Pursuant to Standing Order 108(2) the committee commenced its study on instructions to Law Clerk and Parliamentary Counsel.

Motion

Michelle Rempel Garner moved, — That the Chair be instructed to present the following report to the House forthwith, provided that dissenting or supplementary opinions, pursuant to Standing Order 108(1)(b), shall be filed with the clerk of the committee within 24 hours of adoption of this motion:

The Standing Committee on Health has met pursuant to its Order of Reference of Monday, October 26, 2020, and recommends the following:

That the Law Clerk and Parliamentary Counsel, when vetting documents under subparagraph (aa)(ii) of the Order adopted by the House on Monday, October 26, 2020, be instructed to prioritize the vetting in the following order: (a) documents, produced by the Public Health Agency of Canada in response to paragraphs (y) and (z) of the Order, concerning vaccines; (b) all other documents, produced in response to paragraphs (y) and (z) of the Order, concerning vaccines; (c) documents, produced in response to paragraph (w) of the Order, concerning rapid testing; (d) other categories of documents which may be specified, from time to time, by the Standing Committee on Health; and (e) all other documents; that all documents be circulated to the committee in both official languages; and

That the Standing Committee on Health may, on the request of the Law Clerk and Parliamentary Counsel, grant one or more extensions of the deadline, prescribed by subparagraph (aa)(ii) of the Order adopted by the House on Monday, October 26, 2020, for his vetting of documents, provided that he shall provide the Committee with a weekly status report on the vetting process..

Debate arose thereon.

Motion

Mike Kelloway moved, — That the debate be now adjourned.

The question was put on the motion and it was negatived on the following recorded division:

YEAS: Darren Fisher, Mike Kelloway, Marcus Powlowski, Tony Van Bynen, Sameer Zuberi — 5;

NAYS: John Barlow, Don Davies, Tom Kmiec, Larry Maguire, Michelle Rempel Garner, Luc Thériault — 6.

The question was put on the motion and it was agreed to on the following recorded division:

YEAS: John Barlow, Don Davies, Tom Kmiec, Larry Maguire, Michelle Rempel Garner, Luc Thériault — 6;

NAYS: Darren Fisher, Mike Kelloway, Marcus Powlowski, Tony Van Bynen, Sameer Zuberi — 5.

Patented Medicine Prices Review Board
• Douglas Clark, Executive Director
• Mitchell Levine, Chairperson
Pursuant to Standing Order 108(2) and the motion adopted by the committee on Monday, October 26, 2020, the committee resumed its study of the Patented Medicine Prices Review Board’s guidelines.

Douglas Clark and Michell Levine answered questions.

At 3:07 p.m., the committee adjourned to the call of the Chair.



Jean-François Pagé
Clerk of the Committee